Profound Medical Corp. (TSE:PRN) Senior Officer Purchases C$125,480.25 in Stock

Profound Medical Corp. (TSE:PRN) Senior Officer Rashed Osman Dewan purchased 9,765 shares of Profound Medical stock in a transaction dated Thursday, August 15th. The stock was acquired at an average price of C$12.85 per share, with a total value of C$125,480.25.

Profound Medical Trading Down 1.9 %

TSE:PRN opened at C$12.60 on Monday. Profound Medical Corp. has a one year low of C$9.55 and a one year high of C$16.00. The company has a debt-to-equity ratio of 15.78, a quick ratio of 14.98 and a current ratio of 5.41. The firm has a market cap of C$308.45 million, a P/E ratio of -7.08 and a beta of 0.83. The firm has a 50-day simple moving average of C$12.82 and a 200-day simple moving average of C$11.68.

Profound Medical Company Profile

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.